Young Leaders Caucus

Share

Young Leaders Summit participants

About the Young Leaders Caucus

The American Cancer Society Cancer Action Network Young Leaders Caucus is the ideal space for volunteers, aged 18-35, to connect and engage in cancer advocacy throughout the year. The Young Leaders Caucus fosters opportunities to connect young people to the work of ACS CAN and to others with similar interests. We work to elevate the perspectives of young people, including cancer survivors, about childhood and AYA, to inform and influence ACS CAN priorities and considerations.

Meet the steering committee! These are the volunteer leaders of the YLC.  Learn more their role in the YLC

Check out photos from our various events here.

We release quarterly newsletters detailing our activity,  upcoming events, and any timely announcements.

Find out what is happening next with ACS CAN and the YLC.

Find all the resources you need to get more engaged with the YLC.

Find a list of our working groups and their ongoing projects here.

Latest Updates

April 3, 2026
National

As the administration releases its proposed budget for Fiscal Year 2027, the American Cancer Society Cancer Action Network (ACS CAN) is calling on Congress to maintain its longstanding bipartisan commitment to robust, increased investments in cancer research and prevention.

April 1, 2026
National

The American Cancer Society Cancer Action Network (ACS CAN) announces two new members alongside newly-elected leadership officers to the Board of Directors for 2026.

March 23, 2026
National

As new federal data show continued declines in youth tobacco use, the American Cancer Society Cancer Action Network (ACS CAN) is urging the U.S. Food and Drug Administration (FDA) to reject any effort to authorize new flavored tobacco products, including coffee, mint and cinnamon. Flavors have long been used by Big Tobacco to appeal to and addict young people to their deadly products.

February 18, 2026
National

The American Cancer Society Cancer Action Network (ACS CAN) released today results from a survey exploring cancer patients and survivors’ attitudes toward vaccines.